# Deep Learning (nnU-Net)-Based Segmentation of Primary HPV-Positive OPSCC: Contrast-Enhanced T1-Weighted Fat-Suppressed Versus Non-Contrast-Enhanced T2-Weighted Fat-Suppressed MRI (Paired Single-Center Study)

**Authors:** Viktoriia Zarovniaeva, Ramkumar Rajabathar Babu Jai Shanker, Amogh Shetty, Daniel T. Ginat

PMC · DOI: 10.3390/diagnostics16050658 · Diagnostics · 2026-02-25

## TL;DR

This study compares AI-based tumor segmentation in HPV-positive OPSCC using different MRI sequences and finds that non-contrast T2-weighted imaging performs as well as contrast-enhanced methods.

## Contribution

The study provides the first systematic evaluation of contrast-enhanced versus non-contrast MRI for automated segmentation of HPV-positive OPSCC tumors.

## Key findings

- Segmentation performance using non-contrast T2 sequences was comparable to combined contrast-enhanced and T2 sequences.
- No significant differences in Dice scores or qualitative ratings were found between sequence configurations.
- The results suggest feasibility of contrast-sparing segmentation when contrast agents cannot be used.

## Abstract

Background/Objectives: While deep learning-based AI algorithms have been shown to perform well for OPSCC tumor segmentation, the relative value of contrast-enhanced versus T2-weighted sequences for automated segmentation has not been systematically evaluated. In this study, we compared the sequence-specific deep learning performance on contrast-enhanced T1-weighted fat-suppressed and T2-weighted fat-suppressed MRI in HPV-positive OPSCC. Methods: Pretreatment MRI from 39 patients with paired sequences from a single center were retrospectively analyzed. OPSCC primary tumors were manually segmented using both sequences, which served as the ground truth. Three sequence-specific configurations were evaluated: contrast-enhanced (CE), T2-only, and combined CE + T2. Quantitative evaluation was carried out on aggregated out-of-fold predictions using Dice score (primary), Surface-Dice@2mm (secondary), and other boundary and volumetric metrics, and paired comparisons (combined vs. T2-only; CE-only vs. T2-only) were performed using an exact Wilcoxon signed-rank test. Qualitative evaluation was performed on 4-point ordinal acceptability ratings recorded using a blind reader study, and the ratings were compared using the exact Wilcoxon signed-rank test (pairwise) and dichotomized acceptability using the McNemar test. Results: Median Dice was comparable across configurations (0.63 for CE + T2, 0.60 for T2-only, and 0.55 for CE-only). Median Surface-Dice@2mm was highest for the combined configuration (0.62), followed by CE-only (0.6) and T2-only (0.57). Median ASSD were 2.71, 2.98, and 2.98 mm, and median HD95 were 11.39, 15.0, and 11.3 mm for combined, CE, and T2, respectively. The median GTV differences (−1.31, −1.29, and −1.49 mL for combined, T2, and CE, respectively) showed a slight bias toward under-segmentation across all configurations. No significant differences in Dice scores were observed for combined vs. T2 (p = 0.11) or contrast-enhanced vs. T2-only (p = 0.98). Similarly, qualitative analysis also showed no evidence of performance difference for ratings and acceptability rates across sequence configurations (paired Wilcoxon, p ≥ 0.35; McNemar, p = 1.00). Conclusions: In this single-center study, the segmentation performance using non-contrast sequences was comparable to that using both contrast-enhanced and non-contrast sequences. The drop in performance when the contrast-enhanced sequences were excluded from the combination was not significant. These findings justify multi-center validation to support the feasibility of contrast-sparing automated primary OPSCC segmentation when use of contrast agents is contraindicated.

## Full-text entities

- **Diseases:** OPSCC tumor (MESH:D009369), primary tumors (MESH:D001932)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12985114/full.md

## Figures

8 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12985114/full.md

## References

36 references — full list in the complete paper: https://tomesphere.com/paper/PMC12985114/full.md

---
Source: https://tomesphere.com/paper/PMC12985114